Early Ambulation After Adductor Canal Block for Total Knee Arthroplasty
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01459861|
Recruitment Status : Terminated (Administratively closed early)
First Posted : October 26, 2011
Last Update Posted : March 6, 2013
|Condition or disease||Intervention/treatment||Phase|
|Pain Osteoarthritis||Procedure: Canal Block and Capsular Injection Procedure: Femoral Nerve Block with Tibial Nerve Block||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||11 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||Assessment of Early Ambulation in Patients Receiving Continuous Adductor Canal Block With Ultrasound Guided Posterior Capsular Knee Injection vs. Femoral Nerve Block With Tibial Nerve Block Following Total Knee Replacement|
|Study Start Date :||October 2011|
|Actual Primary Completion Date :||September 2012|
|Actual Study Completion Date :||September 2012|
Experimental: Canal Block and Capsular Injection
Adductor canal block with a continuous catheter and ultrasound guided posterior capsular injection with local anesthetic solution.
Procedure: Canal Block and Capsular Injection
Continuous Adductor canal block with 15ml of ropivacaine 0.2% with epinephrine 1:400,000 followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days post operatively. This is combined with ultrasound guided posterior capsular knee injection with 30ml ropivacaine 0.2% with epinephrine 1:400,000.
Active Comparator: Femoral with Tibial Nerve Block
Continuous femoral nerve block with catheter and selective tibial nerve block in the popliteal fossa.
Procedure: Femoral Nerve Block with Tibial Nerve Block
Continuous femoral nerve block with 15ml of ropivacaine 0.2% followed by an infusion of ropivacaine 0.2% at 6ml per hour for 2 days after surgery combined with tibial nerve block in the popliteal fossa with ropivacaine 0.5% up to 15ml.
- Ability to ambulate post operatively. [ Time Frame: Up to 3 days (72 hours) post surgery. ]Ability to ambulate and perform tasks of the rehabilitation program and reach rehabilitation milestones after total knee arthroplasty.
- Pain scores at rest and with knee flexion. [ Time Frame: Up to 3 days ( 72 hours) after surgery ]Measures of pain score using numeric pain rating scale (0=no pain, 10=worst pain) completed by patient in recovery room and every 6 hours for a 72 hour period after discharge from recovery room.
- Pain Medication Consumption [ Time Frame: Up to 3 days (72 hours) post surgery ]Amount of opioid consumption post surgery for 72 hours.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01459861
|United States, Connecticut|
|Saint Francis Hospital and Medical Center|
|Hartford, Connecticut, United States, 06105|
|Principal Investigator:||Sanjay Sinha, M.D.||Saint Francis Memorial Hospital|